spacer
home > pmps > autumn 2008 > flexible packaging protects against contamination
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Flexible Packaging Protects Against Contamination

This article gives an overview of the regulatory background on the prevention of contamination during the manufacturing and packing process of APIs, drugs or vaccines. Flexible packaging could be an ideal solution, providing suitable protection for this purpose at a relatively low cost.

Fulfilment of regulatory compliance according to European Pharmacopoeia (EP) or United States Pharmacopeia (USP) is often a primary concern, along with suitable documentation and traceability of all qualityrelated items. However, flexible packaging has to fulfil further requirements; the cleanliness of both high-purity bulk material and the production area have to be protected.

Pharmaceutical and medical products are increasingly closely linked to cleanliness. The gap between the requirements of hospital used materials and the needs of the pharmaceutical industry is growing continuously. The cleanliness required for pharmaceuticals, especially for sterile active...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Benjamin Kepp has worked for Bischof + Klein GmbH & Co KG since 2000. In his apprenticeship he had the chance to combine working for B+K with studying economics and commercial law. A further study has successfully been finished with a state-approved BA thereafter. Nowadays, he is engaged as part of the Product Management for CleanFlex® packaging materials.
spacer
Benjamin Kepp
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo includes Sheremetyevo Airport near Moscow to its cargo flights network.

As the fastest growing brand among the global air cargo carriers with its extensive flights network, Turkish Cargo included Sheremetyevo Airport (SVO), known as being the most important airport in Russia in terms of cargo activities, to its direct cargo flight destinations network.
More info >>

White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>

 
Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement